Geneiqlab is a molecular diagnostics company based in The Colony, Texas. They are dedicated to shaping the future of precision medicine by providing actionable insights through advanced genomics and molecular testing. Their solutions cover two main areas: Pharmacogenomics (PGx) and Infectious Diseases (IDx).

In the field of Pharmacogenomics, Geneiqlab utilizes the latest innovations to determine how genetic variability influences patients' response to drugs. By analyzing DNA, they deliver personalized clinical guidance to healthcare professionals for precise treatment guidance. In Infectious Diseases, Geneiqlab leverages RNA and DNA testing to accurately detect specific pathogens and present the resistant genes associated with these pathogens.

Through the use of advanced artificial intelligence and evidence-based medicine, they provide healthcare professionals with intelligent solutions for tailored treatment guidance. Geneiqlab prides itself on being fast, easy, and accurate. Their digital platform allows for test results to be delivered within 24 hours, ensuring effective medical care can be provided promptly.

Their non-invasive methods and user-friendly online portal provide convenience and accessibility to patients and medical staff. By utilizing the gold standard in molecular testing, Geneiqlab ensures accurate and reliable results. With their expertise in both PGx and IDx, Geneiqlab has also played a vital role during the COVID-19 pandemic.

They have provided PCR testing and on-site vaccinations to schools, corporations, and community organizations, supporting the fight against the virus. As a CLIA licensed and COLA certified laboratory, Geneiqlab operates with state-of-the-art precision molecular diagnostic instrumentation. They have received high praise for their timely results, accuracy, and excellent support from their team members.

Overall, Geneiqlab is committed to advancing precision medicine, providing tailored solutions, and delivering exceptional service to their clients